Unlock stock picks and a broker-level newsfeed that powers Wall Street.

OTC Markets EXMKT - Delayed Quote USD

Amexdrug Corporation (AXRX)

Compare
0.0020
0.0000
(0.00%)
As of April 14 at 4:00:00 PM EDT. Market Open.
Loading Chart for AXRX
  • Previous Close 0.0000
  • Open 0.0021
  • Bid --
  • Ask --
  • Day's Range 0.0021 - 0.0021
  • 52 Week Range 0.0020 - 0.0021
  • Volume 1,280
  • Avg. Volume 6
  • Market Cap (intraday) 338,820
  • Beta (5Y Monthly) -0.63
  • PE Ratio (TTM)
  • EPS (TTM) 0.0000
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Amexdrug Corporation, a pharmaceutical and cosmeceutical company, through its subsidiaries, primarily distributes pharmaceutical products. It is also involved in the research, development, manufacture, and sale of pharmaceutical drugs, cosmetics, and medical devices. The company operates in two segments, Distribution and Health and Beauty Products. In addition, it engages in the distribution of prescription and over-the-counter drugs, non-drug products, and health and beauty products; and private manufacturing and labeling activities. Further, the company manufactures and sells facial and body creams, arthritic pain relief medications, and hair and nail care products to pharmacies, beauty salons, beauty supply stores, and other fine shops. Amexdrug Corporation markets its products under the Sponix name. The company distributes its products through its subsidiaries primarily to independent pharmacies and secondarily to small-sized pharmacy chains, alternative care facilities, and other wholesalers and retailers in the state of California. The company was formerly known as Harlyn Products, Inc. and changed its name to Amexdrug Corporation in April 2000 to reflect the change in its business to the sale of pharmaceutical products. Amexdrug Corporation was founded in 1963 and is based in Commerce, California.

www.amexdrug.com

9

Full Time Employees

December 31

Fiscal Year Ends

Recent News: AXRX

View More

Performance Overview: AXRX

Trailing total returns as of 4/15/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

AXRX
0.00%
S&P 500 (^GSPC)
7.82%

1-Year Return

AXRX
4.76%
S&P 500 (^GSPC)
7.11%

3-Year Return

AXRX
99.03%
S&P 500 (^GSPC)
23.42%

5-Year Return

AXRX
97.66%
S&P 500 (^GSPC)
94.78%

Compare To: AXRX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: AXRX

View More

Valuation Measures

Annual
As of 4/14/2025
  • Market Cap

    338.82k

  • Enterprise Value

    338.82k

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.81%

  • Return on Assets (ttm)

    11.25%

  • Return on Equity (ttm)

    28.78%

  • Revenue (ttm)

    9.17M

  • Net Income Avi to Common (ttm)

    165.83k

  • Diluted EPS (ttm)

    0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    168.01k

  • Total Debt/Equity (mrq)

    146.01%

  • Levered Free Cash Flow (ttm)

    -529.47k

Research Analysis: AXRX

View More

Company Insights: AXRX

Research Reports: AXRX

View More

People Also Watch